Härmä Harri, Rozwandowicz-Jansen Anita, Martikkala Eija, Frang Heini, Hemmilä Ilkka, Sahlberg Niko, Fey Vidal, Perälä Merja, Hänninen Pekka
Laboratory of Biophysics, University of Turku, Turku, Finland.
J Biomol Screen. 2009 Sep;14(8):936-43. doi: 10.1177/1087057109341657. Epub 2009 Aug 14.
In this article, a single-label separation-free fluorescence technique is presented as a potential screening method for cell-based receptor antagonists and agonists.The time-resolved fluorescence technique, quenching resonance energy transfer (QRET), relies on a single-labeled binding partner in combination with a soluble quencher. The quencher efficiently suppresses the luminescence of the unbound labeled ligand, whereas the luminescence of the bound fraction is not affected. This approach allows the development of cell-based screening assays in a simple and cost-effective manner. The authors have applied the technique to the screening of beta(2)-adrenoreceptor (beta(2)AR) antagonists and agonists in intact human embryonic kidney HEK293(i) cells overexpressing human beta(2)-adrenergic receptors. Two antagonists (propranolol, alprenolol) and 2 agonists (metaproterenol, terbutaline) for beta(2)AR were investigated in a displacement assay using europium(III)-labeled pindolol ligand. The assay Z' values ranged from 0.68 to 0.78, the coefficient of variation was less than 10%, and the K(i) values were 19 nM for propranolol and alprenolol and 14 and 5.9 microM for metaproterenol and terbutaline, respectively. The QRET technique with beta(2)AR was also applied to LOPAC compound library screening, yielding nearly error-free recognition of known binders. This simple and cost-effective technique can be readily adapted to laboratory and industrial-scale screening.
在本文中,一种单标记无分离荧光技术被作为一种用于基于细胞的受体拮抗剂和激动剂的潜在筛选方法提出。时间分辨荧光技术,即猝灭共振能量转移(QRET),依赖于与可溶性猝灭剂结合的单标记结合伴侣。猝灭剂能有效抑制未结合的标记配体的发光,而结合部分的发光不受影响。这种方法能够以简单且经济高效的方式开发基于细胞的筛选分析方法。作者已将该技术应用于在过表达人β2 -肾上腺素能受体的完整人胚肾HEK293(i)细胞中筛选β2 -肾上腺素受体(β2AR)拮抗剂和激动剂。在使用铕(III)标记的吲哚洛尔配体的置换分析中研究了两种β2AR拮抗剂(普萘洛尔、阿普洛尔)和两种激动剂(间羟异丙肾上腺素、特布他林)。分析的Z'值范围为0.68至0.78,变异系数小于10%,普萘洛尔和阿普洛尔的K(i)值为19 nM,间羟异丙肾上腺素和特布他林的K(i)值分别为14和5.9 μM。带有β2AR的QRET技术也应用于LOPAC化合物库筛选,对已知结合物的识别几乎无误差。这种简单且经济高效的技术可轻松适用于实验室和工业规模的筛选。